financetom
Business
financetom
/
Business
/
Resideo Technologies Q2 Adjusted Net Income Rises, Revenue Falls; Ups 2024 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Resideo Technologies Q2 Adjusted Net Income Rises, Revenue Falls; Ups 2024 Guidance
Aug 8, 2024 2:42 PM

05:20 PM EDT, 08/08/2024 (MT Newswires) -- Resideo Technologies ( REZI ) reported Q2 adjusted net income of $0.62 per diluted share, up from $0.48 a year earlier.

Analysts polled by Capital IQ expected $0.49.

Revenue for the quarter ended June 29 fell to $1.59 billion from $1.60 billion a year earlier. Analysts surveyed by Capital IQ expected $1.53 billion.

For Q3, the company expects adjusted EPS of $0.49 to $0.59 on revenue of $1.79 billion to $1.83 billion. Analysts expect $0.59 on revenue of $1.57 billion.

For 2024, Resideo ( REZI ) increased its adjusted EPS guidance to $2.15 to $2.35 from $1.90 to $2.30 previously. It also raised revenue outlook to $6.68 billion to $6.76 billion from $6.08 billion to $6.28 billion. Analysts expect EPS of $2.14 on revenue of $6.16 billion.

Price: 19.23, Change: +0.01, Percent Change: +0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
IDEAYA Biosciences Selects Move-Forward Expansion Dose for Mid-Stage Trial of IDE397 Monotherapy
Apr 22, 2024
08:45 AM EDT, 04/22/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Monday that it has selected a move-forward expansion dose for a mid-stage trial evaluating its IDE397 monotherapy in MTAP-deletion squamous non-small cell lung cancer, or NSCLC. Squamous NSCLC has been identified as the most sensitive tumor type of IDE397 monotherapy, the company said. There are more than...
Satellogic Commits to Backing Amazon Rainforest Monitoring Project
Satellogic Commits to Backing Amazon Rainforest Monitoring Project
Apr 22, 2024
08:49 AM EDT, 04/22/2024 (MT Newswires) -- Satellogic ( SATL ) said Monday it signed a letter of intent with O.N.E. Amazon to advance conservation goals. Financial terms of the preliminary deal were not disclosed. Satellogic ( SATL ) will use its technology to power O.N.E. Amazon's project to create what it describes as an Internet of Forests, a network...
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug
Apr 22, 2024
08:47 AM EDT, 04/22/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Monday that it has signed an in-license agreement with Cornell University to expedite the development of investigational gene therapy candidate LX2006 to treat Friedreich ataxia cardiomyopathy. Under the deal, Lexeo said it has acquired certain rights, including rights to current and future data generated in an ongoing...
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Kroger, Albertsons amend asset sale agreement with C&S Wholesale
Apr 22, 2024
(Reuters) -Kroger ( KR ) and Albertsons Cos ( ACI ) said on Monday that they have amended their definitive agreement with C&S Wholesale Grocers for the sale of assets in connection with their proposed merger. The companies have updated their divestiture package to increase the total store count by 166 to include 579 stores that will be sold to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved